Tigermed Reports Trading Halt of Subsidiary Frontage Pending Takeover Code Announcement

Bulletin Express10-22 08:02

Hangzhou Tigermed Consulting Co., Ltd. (Tigermed) disclosed that trading in the shares of its Hong Kong-listed subsidiary, Frontage Holdings Corporation, was halted at 9:00 a.m. on 22 October 2026. The suspension precedes an upcoming announcement by Frontage required under the Hong Kong Code on Takeovers and Mergers, which is expected to contain inside information.

Tigermed confirmed compliance with Rule 13.09(2) of the Hong Kong Listing Rules and the Inside Information Provisions of the Securities and Futures Ordinance. The parent company stated it will issue additional announcements as warranted and adhere to all relevant regulatory requirements.

Management cautioned shareholders and potential investors that there is no assurance the transaction involving Frontage will proceed. Market participants are advised to exercise caution when dealing in Tigermed securities.

The announcement was authorized by the board of Tigermed and signed by Chairman Ye Xiaoping on 22 October 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment